Effects of Metformin in Heart Failure Patients

Summary

Hypothesis: In patients, who have diabetes type 2, are treated with metformin, and are admitted for HF, leads to reduced insulin requirements, as measured in units of insulin, with no negative impact on patient safety. This is a single center, prospective trial. Subjects will be randomized to initiate metformin (starting dose 500mg orally once daily up to a maximum dose of 2,500mg daily) OR be placed on insulin products for management of their type 2 diabetes mellitus.

Timeline

Start

2016-11

Primary completion

2018-09-10

Completion

2018-09-10

Outcome

Outcome not reported

Stopped (Enrollment): “failure to enroll participants”

Drugs

Indications